306 related articles for article (PubMed ID: 10545531)
1. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
Shiau MY; Huang CN; Liao JH; Chang YH
J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
[TBL] [Abstract][Full Text] [Related]
5. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
[TBL] [Abstract][Full Text] [Related]
6. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
Hansen L
Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
[TBL] [Abstract][Full Text] [Related]
8. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.
Stoffers DA; Stanojevic V; Habener JF
J Clin Invest; 1998 Jul; 102(1):232-41. PubMed ID: 9649577
[TBL] [Abstract][Full Text] [Related]
9. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
Małecki M; Krolewski AS
Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
[TBL] [Abstract][Full Text] [Related]
10. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus.
Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Sriussadaporn S; Vannaseang S; Banchuin N; Yenchitsomanus PT
Clin Endocrinol (Oxf); 2009 Jun; 70(6):847-53. PubMed ID: 18811724
[TBL] [Abstract][Full Text] [Related]
11. Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families.
Domínguez-López A; Miliar-García A; Segura-Kato YX; Riba L; Esparza-López R; Ramírez-Jiménez S; Rodríguez-Torres M; Canizales-Quinteros S; Cabrera-Vásquez S; Fragoso-Ontiveros V; Aguilar-Salinas CA; Altamirano-Bustamante N; Calzada-León R; Robles-Valdés C; Bravo-Ríos LE; Tusié-Luna MT
JOP; 2005 May; 6(3):238-45. PubMed ID: 15883474
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
[TBL] [Abstract][Full Text] [Related]
13. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
Stride A; Hattersley AT
Ann Med; 2002; 34(3):207-16. PubMed ID: 12173691
[TBL] [Abstract][Full Text] [Related]
14. Genetics of type 2 diabetes mellitus.
Malecki MT
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
[TBL] [Abstract][Full Text] [Related]
15. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family.
Cockburn BN; Bermano G; Boodram LL; Teelucksingh S; Tsuchiya T; Mahabir D; Allan AB; Stein R; Docherty K; Bell GI
J Clin Endocrinol Metab; 2004 Feb; 89(2):971-8. PubMed ID: 14764823
[TBL] [Abstract][Full Text] [Related]
16. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
[TBL] [Abstract][Full Text] [Related]
17. Who should have genetic testing for maturity-onset diabetes of the young?
Naylor R; Philipson LH
Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318
[TBL] [Abstract][Full Text] [Related]
18. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
Kristinsson SY; Thorolfsdottir ET; Talseth B; Steingrimsson E; Thorsson AV; Helgason T; Hreidarsson AB; Arngrimsson R
Diabetologia; 2001 Nov; 44(11):2098-103. PubMed ID: 11719843
[TBL] [Abstract][Full Text] [Related]
19. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing.
Chapla A; Mruthyunjaya MD; Asha HS; Varghese D; Varshney M; Vasan SK; Venkatesan P; Nair V; Mathai S; Paul TV; Thomas N
Clin Endocrinol (Oxf); 2015 Apr; 82(4):533-42. PubMed ID: 25041077
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factors and type 2 diabetes.
Froguel P
Schweiz Med Wochenschr; 1998 Dec; 128(49):1936-9. PubMed ID: 9887471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
